top of page

BIO 2026: Montara is trying to open more CNS treatment possibilities by using one drug that blocks a target-specific drug’s activity in the periphery in combo with a brain active and concentrated one

Jun 22
1 min read

CEO Nicholas Hertz describes this approach, which was recently made famous through the success of Karuna. Andrew Miller, a founder of Karuna, recently joined Montara's board.




Coverage brought to you by



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Mispro_Logo_2023_Primary-4.png

Mispro is an AAALAC-accredited contract vivarium organization (CVO) offering a network of full-service vivarium rental lab facilities for preclinical in vivo rodent studies. Along with access to state-of-the-art lab spaces, Mispro supports its clients with comprehensive laboratory animal research services, including husbandry, veterinary, technical, and regulatory compliance oversight. With locations in all major U.S. biotech hubs, Mispro is committed to helping biosciences companies of all sizes and therapeutic indications achieve their research goals.

bottom of page